216 related articles for article (PubMed ID: 23248048)
1. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
[TBL] [Abstract][Full Text] [Related]
3. Targeted deletion of HAI-1 increases prostasin proteolysis but decreases matriptase proteolysis in human keratinocytes.
Lu DD; Gu Y; Li SA; Barndt RJ; Huang SM; Wang JK; Su HC; Johnson MD; Lin CY
Hum Cell; 2021 May; 34(3):771-784. PubMed ID: 33486722
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth.
Fan B; Brennan J; Grant D; Peale F; Rangell L; Kirchhofer D
Dev Biol; 2007 Mar; 303(1):222-30. PubMed ID: 17174946
[TBL] [Abstract][Full Text] [Related]
5. Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.
Kawaguchi M; Takeda N; Hoshiko S; Yorita K; Baba T; Sawaguchi A; Nezu Y; Yoshikawa T; Fukushima T; Kataoka H
Am J Pathol; 2011 Oct; 179(4):1815-26. PubMed ID: 21840293
[TBL] [Abstract][Full Text] [Related]
6. Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.
Szabo R; Kosa P; List K; Bugge TH
Am J Pathol; 2009 Jun; 174(6):2015-22. PubMed ID: 19389929
[TBL] [Abstract][Full Text] [Related]
7. Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.
Nagaike K; Kawaguchi M; Takeda N; Fukushima T; Sawaguchi A; Kohama K; Setoyama M; Kataoka H
Am J Pathol; 2008 Nov; 173(5):1464-75. PubMed ID: 18832587
[TBL] [Abstract][Full Text] [Related]
8. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.
Szabo R; Molinolo A; List K; Bugge TH
Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341
[TBL] [Abstract][Full Text] [Related]
9. Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas.
Chou FP; Chen YW; Zhao XF; Xu-Monette ZY; Young KH; Gartenhaus RB; Wang JK; Kataoka H; Zuo AH; Barndt RJ; Johnson M; Lin CY
Am J Pathol; 2013 Oct; 183(4):1306-17. PubMed ID: 24070417
[TBL] [Abstract][Full Text] [Related]
10. Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation.
Lai CH; Lai YJ; Chou FP; Chang HH; Tseng CC; Johnson MD; Wang JK; Lin CY
PLoS One; 2016; 11(4):e0152904. PubMed ID: 27043831
[TBL] [Abstract][Full Text] [Related]
11. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
[TBL] [Abstract][Full Text] [Related]
12. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
[TBL] [Abstract][Full Text] [Related]
13. Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.
Szabo R; Lantsman T; Peters DE; Bugge TH
Development; 2016 Aug; 143(15):2818-28. PubMed ID: 27385010
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin.
Lee SP; Kao CY; Chang SC; Chiu YL; Chen YJ; Chen MG; Chang CC; Lin YW; Chiang CP; Wang JK; Lin CY; Johnson MD
PLoS One; 2018; 13(2):e0192632. PubMed ID: 29438412
[TBL] [Abstract][Full Text] [Related]
17. Insufficiency of hepatocyte growth factor activator inhibitor-1 confers lymphatic invasion of tongue carcinoma cells.
Izumi A; Yamamoto K; Kawaguchi M; Yamashita F; Fukushima T; Kiwaki T; Tanaka H; Yamashita Y; Kataoka H
Cancer Sci; 2022 Jun; 113(6):2179-2193. PubMed ID: 35332604
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
Domoto T; Takino T; Guo L; Sato H
Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes.
Chen YW; Xu Z; Baksh AN; Wang JK; Chen CY; Swanson R; Olson ST; Kataoka H; Johnson MD; Lin CY
PLoS One; 2013; 8(5):e62826. PubMed ID: 23675430
[TBL] [Abstract][Full Text] [Related]
20. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]